Patent · US Active

Anti-IL-6 antibody

US12065488B2 · kind B2 · utility

0Cited by

36References

4Claims

0Family size

Assignees

JANSSEN BIOTECH, INC. · US
Applied Molecular Evolution, Inc. · US

Inventors

Yan Chen · Santa Clara, US
Debra Gardner · Bear, US
David Knight · Berwyn, US
Michael W. Lark · Devon, US
Bailin Liang · Gilbertsville, US
David Matthew Marquis · Encinitas, US
David Shealy · Downingtown, US
Eric Michael Smith · Galveston, US
Xiao-yu R. Song · Bound Brook, US
Vedrana Stojanovic-Susulic · Princeton Junction, US
Raymond Sweet · Via Enrico Fermi, US
Susan Tam · Boothwyn, US
Alain P. Vasserot · South San Francisco, US
Sheng-Jiun Wu · Broomall, US
Jing Yang · Cambridge, US

Key dates

Filing date	Nov 1, 2021
Grant date	Aug 20, 2024
Priority date	—
Expiry date	Nov 11, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Anti-IL-6 antibodies and antirheumatics are useful to treat and suppress IL-6 related conditions, such as rheumatoid arthritis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.